ARISE is committed to full transparency in how MAST benchmarks are developed, funded, and operated. This page discloses our funding sources, independence policies, and conflict of interest rules.
Transparency in funding is essential to maintaining public trust in our evaluations. The table below discloses all funding sources that support MAST development and operations.
| Source | Type | Period | Purpose |
|---|---|---|---|
| Stanford Medicine | Institutional | 2024–Present | Core research infrastructure and personnel |
| Harvard Medical School | Institutional | 2024–Present | Clinical validation and annotation support |
| NIH/NIDDK | Federal Grant | 2024–2026 | Benchmark development and data curation |
ARISE maintains strict conflict of interest policies to protect the integrity of MAST evaluations. The following rules apply to all team members, advisors, and collaborators involved in the benchmark process:
During evaluation, model providers submit their systems through our controlled API pipeline. MAST does not share benchmark cases with model providers before or after evaluation. All evaluation data is processed in a secure environment, and model outputs are stored only for the duration needed to complete scoring.
De-identified clinical cases used in the benchmark are sourced from existing institutional research datasets with appropriate IRB approvals. No patient-identifiable information is included in any benchmark case. Model providers' API keys and system configurations are handled under standard data protection protocols and are not retained after evaluation completion.
For questions about our transparency practices, funding disclosures, or conflict of interest policies, please reach out to our transparency team.
transparency@arise-ai.org